BPGbio, Inc.

Scientist - Immunoassay and Biomarker Development

BPGbio, Inc.  •  $105k - $115k/yr  •  Waltham, MA (Onsite)  •  3 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

The Scientist – Immunoassay and Biomarker Development’s primary focus is on immunoassay development, screening, and biomarker projects.

ESSENTIAL DUTIES AND RESPONSIBILITIES:

  • Assist in ligand binding assay method development (MSD, ELISA) and provide technique and application support for immunoassays transferred to downstream users.
  • Test antibody quality for purity (SDS-PAGE), specificity (Western Blot, ELISA), and concentration (Nanodrop, BCA).
  • Conduct assay performance validation.
  • Conduct compound screening utilizing the developed assays.
  • Develop pharmacodynamic biomarker assays to support internal clinical development.
  • Perform protein analysis (SDS/native-PAGE, Western Blot, and Immunoprecipitation).
  • Develop experiment protocols and prepare SOPs.
  • Perform and manage cell culture experiments for MOA, PD biomarker mechanistic insight, as well as biomarker assessment.
  • Perform laboratory experiments carefully and troubleshoot to solve problems.
  • Meticulously document experiment results in laboratory notebooks and databases timely.
  • Analyze, summarize, and present experimental results to managers and other team members.
  • Prepare experiment and project reports as required.
  • Order and stock laboratory supplies for a continuous and consistent workflow.
  • Other duties, as assigned.

REQUIREMENTS:

  • Requires a PhD (1-3 years’ experience) or MS (4-7 years) in biology/biochemistry/chemistry/immunology.
  • Knowledge and prior experience with protein analytical methods, such as ELISA, Protein concentration assays, SDS-PAGE, Western Blot and mass spectrometry (a plus).
  • Prior experience managing cell culture experiments for MOA and biomarker assessment.
  • Qualified applicants must have good pipetting skills, be analytical, and flexible.
BPGbio, Inc.

About BPGbio, Inc.

BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be modeled using bespoke Bayesian AI specifically designed for solving large-scale biology challenges. Headquartered in greater Boston, the company is at the forefront of a new era in medicine, combining biology, multi-modal data, and AI to transform the way we understand, diagnose, and treat disease.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
Waltham, Massachusetts
Year Founded
2006
Social Media